Key benefits of a microfluidic platform for cell culture at a clinically relevant scale (2022)
Attributed to:
Miniaturisation of high throughput healthcare bioreactors for advanced therapeutics
funded by
FLF
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.18609/cgti.2022.151
Publication URI: http://dx.doi.org/10.18609/cgti.2022.151
Type: Journal Article/Review
Parent Publication: Cell and Gene Therapy Insights
Issue: 08